Skip to main content
Clinical Trials/NCT03058120
NCT03058120CompletedNot Applicable

Henry Ford Heart Score Randomized Trial: Rapid Discharge of Patients Evaluated for Possible Myocardial Infarction

Henry Ford Health System0 sites105 target enrollmentStarted: February 19, 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
105
Primary Endpoint
Cost of hospitalization

Study Overview

Brief Summary

This was a prospective randomized, controlled trial designed to quantify the reduction in cost and length of stay of early discharge of emergency department patients evaluated for acute myocardial infarction, who are deemed to be low risk based on a modified HEART score (a score that incorporates troponin biomarker, ecg, patient characteristics, and physician clinical judgment).

Detailed Description

This was a prospective randomized, controlled trial conducted from February 2014 to May 2015 designed to quantify the reduction in cost and length of stay of early discharge of emergency department patients evaluated for acute myocardial infarction, in those deemed to be low risk based on a modified HEART score. Our study enrolled only those deemed low risk, as these are the patients we believe best served by utilization of the HEART score decision aid.

A total of 105 patients evaluated for AMI in the ED with a modified HEART score ≤ 3 (which includes cardiac troponin I < 0.04 ng/ml at 0 and 3 hours) were randomized to immediate discharge (n = 53) vs management in an observation unit with stress testing (n = 52).

The primary endpoints were 30-day total cost and length of stay. Secondary endpoints were all-cause death, nonfatal AMI, rehospitalization for evaluation of possible AMI, and coronary revascularization at 30 days.

That such an early discharge strategy would decrease cost and length of stay is intuitively expected; our goal was to quantify such a reduction.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Single (Investigator)

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • patients 21 years or older
  • patients who presented to the Emergency Department with symptoms suspicious for AMI.
  • patients for whom the ED physician's intention to send the patient to the observation unit for stress testing

Exclusion Criteria

  • Cardiac Troponin I > 0.04 ng/mL at 0 or 3 hours
  • clinical presentation warranting admission
  • inability or unwillingness to consent
  • trauma as etiology of presenting symptoms.

Outcomes

Primary Outcomes

Cost of hospitalization

Time Frame: 30 days

Total charges accrued during index hospitalization, as well as costs related to index hospitalization up to 30 days after index discharge

Length of stay

Time Frame: up to 1 week

Total length of stay of index hospitalization

Secondary Outcomes

  • 30-day MACE(30 days after index hospitalization)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tiberio Frisoli

MD, Member of Heart and Vascular Institute in the Division of Cardiology

Henry Ford Health System

Similar Trials